Factor VIII recombinant protein is commonly produced in:
Coagulation factor VIII complex multidomain glycoprotein organized signal peptide 19 residues followed domains A1 a1 A2 a2 B a3 A3 C1 C2 totaling 2351 aa 280 kDa requiring extensive co-translational post-translational processing secretory pathway. Nascent polypeptide translocates Sec61 translocon ER lumen signal peptidase cleaves signal oligosaccharyltransferase adds high-mannose oligosaccharides 25 asparagine X Ser Thr motifs protein disulfide isomerase forms 8 disulfide bonds calnexin calreticulin cycle glucosidase II monitors folding peptidyl prolyl isomerase assists. Golgi further trims mannose adds complex sialylated glycans glycosyltransferases sulfates tyrosines 346 718 719 tyrosylprotein sulfotransferase essential vWF binding incorporates copper ions. E. coli cytoplasm lacks ER glycosylation sulfation chaperone BiP leading misfolded aggregates inclusion bodies lacking cofactor activity eliciting neutralizing antibodies exposed neoepitopes. Chinese hamster ovary cells possess mammalian processing enzymes secrete active factor serum-free medium supplemented vWF stabilizing. Stable clones expressing B-domain-deleted FVIII CMV promoter purified monoclonal antibody immunoaffinity anion exchange preserving specific activity around 5000 IU per mg therapeutic use.
Ref: Blood Factor VIII CHO Production Kaufman 1988; FDA Recombinant Factor VIII Manufacturing Guidelines; Alberts Protein Glycosylation Mammalian Cells Chap 15.